Skip to content

Autism Oxytocin Brain Project

Target Engagement for Intranasal Oxytocin in Autism Spectrum Disorders, an fMRI Dose Response Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03033784
Enrollment
51
Registered
2017-01-27
Start date
2017-05-10
Completion date
2018-10-03
Last updated
2021-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Autism Spectrum Disorder

Keywords

Neuroscience

Brief summary

The main goal of the study is to look at the effects of intranasal oxytocin on the brain in Autism Spectrum Disorder (ASD). Oxytocin is a hormone that exists naturally in the body and the brain, affecting a wide range of social behaviors and emotions. The investigators will study the effects of different treatments (3 doses of oxytocin and one dose of placebo) on brain functional connectivity at rest in patients with ASD, using functional magnetic resonance imaging (fMRI). Investigators also seek to study how the effects of oxytocin treatment can be affected by genetic, immune and environmental factors.

Detailed description

This study consists of investigating the effects of several doses of acute administration of intranasal oxytocin on brain activity in adults with Autism Spectrum Disorder (ASD). There is increasing evidence for the role of intranasal oxytocin (IN-OT) in enhancing social skills in ASD. Nevertheless, there is still a need of determining target engagement for oxytocin's action on brain and behavior. Here, investigators are studying the effects of different doses of IN-OT on the modulation of behavioral outcomes and neural responses in a double blind crossover study in individuals with ASD. The aims of the research are to: 1. Study the effects of IN-OT doses on the modulation of brain functional connectivity between key socio-emotional brain regions during resting state in ASD 2. Study the effects of IN-OT doses on the blood-oxygen-level dependent (BOLD) activity of key emotional and perceptual brain networks in response to social cues (such as faces) 3. Study the effects of IN-OT on the BOLD activity of brain regions during an interactive social environment (ball game) in ASD Investigators will compare the neuroimaging and behavioral results of individuals with ASD to control healthy males who will receive intranasal placebo. Investigators are also investigating the role of genetic factors, behavioral or clinical sub-groups of ASD, immune and environmental factors in modulating the effect of IN-OT on brain and behavior. Participants with ASD will undergo 4 clinical visits during which they receive various randomly assigned doses of intranasal oxytocin and placebo. Both participants and the experimenter will be blind to the type of the treatment administered. There will be only one visit for healthy controls who will all receive placebo spray. The visit for healthy controls will be conducted in a single-blind design. The experimenter will be aware that the subject is receiving placebo. However, the participant will be told that he might receive oxytocin or placebo.

Interventions

DRUG8 International Units (IU) of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 8IU.

DRUG24IU of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 24IU.

DRUG48IU of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 48IU.

DRUGPlacebo

Participants will receive an intranasal placebo to match the oxytocin doses.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

for ASD Participants: * Have an ASD diagnosis based on the Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview (ADI) criteria, gold standards of research-based autism diagnosis * Intelligence quotient (IQ) \> 70 * Normal or corrected-to-normal vision

Exclusion criteria

for ASD Participants: * Recent occurrence of seizures (past 5 years) * Brain damage or head trauma (can be included at discretion of PI and sponsor) * Color blind * Cardiovascular disease * Presence of a severe medical problem * Severe mental retardation * Alcoholism or substance abuse * Asthma (can be included at the discretion of study physician/nurse practitioner if episodes are infrequent and no active problems at time of the study) * Migraine headaches (at the discretion of the nurse practitioner or the study physician) * Claustrophobia (at discretion of study physician/designee/PI) * Pacemakers, cochlear implants, surgical clips or metal fragments Inclusion Criteria for Healthy Age-Matched Controls: * IQ \> 70 * Normal or corrected-to-normal vision

Design outcomes

Primary

MeasureTime frameDescription
Resting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)Post Intervention (Up to 40 minutes after receiving spray) at Study Visits 1, 2, 3 and 4Investigators will study the effects of intranasal oxytocin (IN-OT) on the resting state functional connectivity between key socio-emotional and social salience brain regions using functional magnetic resonance imaging (fMRI). Resting state functional connectivity is a task-independent metric of brain activity that is based on correlations between low-frequency fluctuations of the blood oxygen level-dependent signal between several brain regions. It reflects the strength of a functional connection that is in good agreement with the underlying neuroanatomy and provides a system-level understanding of brain function. Z-scores represent the number of standard deviations from the mean of 0 and range from -3 to +3, and z-scores greater than 0 indicate greater than average resting state functional connectivity.
Blood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesPost Intervention (Up to 70 minutes) at Study Visits 1, 2, 3, and 4BOLD activity level was assessed via fMRI during completion of the face perception task (FPT) of emotional and neutral faces. BOLD scores are reported on a z-scale, with the mean, standard deviation and the minimum and the maximum. This refers to the non-thresholded z-scores that are obtained for each dose before conducting small volume correction analysis.
Percent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskPost Intervention (up to 70 minutes) at Study Visits 1, 2, 3, and 4BOLD activity in social-emotional brain regions during the perception of emotional facial videos were measured during the ball-game task. Mean percent change in contrast of parameter estimates in anatomical regions of interest are presented here. A positive value indicates increased BOLD activity while a negative value indicates decreased BOLD activity.
Oxytocin Plasma ConcentrationVisits 1, 2, 3 and 4 (before spray and 5 minutes after spray)Plasma concentration of oxytocin prior to administration of study intervention and after administration of study intervention will be compared between the different dose levels and placebo. Plasma concentration of oxytocin is expected to increase following administration of intranasal oxytocin.

Secondary

MeasureTime frameDescription
Milliseconds of Visual FixationPost Intervention (Up to 50 minutes) at Study Visits 1, 2, 3 and 4Eye gaze will be recorded via an eye tracker inside the MRI scanner during the face perception task (FPT). Visual fixation between different treatment conditions will be assessed in ASD participants.
Social Learning Test (SLT) Reaction TimePost Intervention (Up to 130 minutes) at Study Visits 1, 2, 3 and 4During the SLT, participants complete an implicit association test using faces and words. The faces that are presented in this task are partners' faces with whom participants played during the ball-game inside the MRI scanner. In this task, there are congruent blocks where neutral faces of positive partners are presented with friendly words and neutral faces of negative partners are presented with unfriendly words. During incongruent blocks, neutral faces of positive partners are presented with unfriendly words and neutral faces of negative partners are presented with friendly words. Participants match the face or the word to one of two categories. Longer reaction time indicates difficulty with selecting a category. Longer reaction time in incongruent trials signifies implicit biases were formed for the positive and negative players such that positive partners from the ball-game are now perceived as friendly and negative partners are now perceived as unfriendly.
Rate of Smiling During Global Clinical InterviewPost Intervention (Up to 180 minutes after receiving spray) at Study Visits 1, 2, 3 and 4Clinical improvements will be rated by a clinician as based on a videotaped interview conducted after the MRI scanning session. Values between the different treatment conditions will be assessed to study the effect of intranasal oxytocin on ASD at the clinical level. The improvement will be assessed based on the quality of social interaction between the experimenter and the participant, specifically as the amount of smiling behavior displayed by participants. Larger values indicate that participants are smiling more frequently.

Countries

United States

Participant flow

Recruitment details

Study participants were recruited from a list of participants in a prior study who agreed to be contacted for future studies. Study procedures were conducted at Emory University Hospital in Atlanta, Georgia. Participant enrollment began May 10, 2017 and all study activities were completed on October 3, 2018.

Participants by arm

ArmCount
Autism Spectrum Disorder (ASD)
Male participants diagnosed with ASD received 12 puffs (6 in each nostril) of intranasal oxytocin (syntocinon) or a placebo during 4 study visits. The order in which the participant received the placebo and three different doses of oxytocin (8, 24, or 48IU) was randomly assigned.
32
Healthy Control
Age matched healthy males received a placebo intranasal spray (12 puffs, 6 per nostril) during one study visit
19
Total51

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005FG006FG007FG008FG009FG010FG011FG012
Overall StudyAnxiety related to MRI scanner0100000000000
Overall StudyWithdrawal by Subject0000000000002

Baseline characteristics

CharacteristicAutism Spectrum Disorder (ASD)TotalHealthy Control
Age, Continuous28.97 years
STANDARD_DEVIATION 5.83
29.67 years
STANDARD_DEVIATION 6.09
30.84 years
STANDARD_DEVIATION 6.5
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
32 Participants51 Participants19 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants7 Participants3 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
White
26 Participants42 Participants16 Participants
Region of Enrollment
United States
32 Participants51 Participants19 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
32 Participants51 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 480 / 320 / 320 / 31
other
Total, other adverse events
3 / 484 / 325 / 325 / 31
serious
Total, serious adverse events
0 / 480 / 320 / 320 / 31

Outcome results

Primary

Blood Oxygen Level Dependent (BOLD) Activity in Response to Social Cues

BOLD activity level was assessed via fMRI during completion of the face perception task (FPT) of emotional and neutral faces. BOLD scores are reported on a z-scale, with the mean, standard deviation and the minimum and the maximum. This refers to the non-thresholded z-scores that are obtained for each dose before conducting small volume correction analysis.

Time frame: Post Intervention (Up to 70 minutes) at Study Visits 1, 2, 3, and 4

Population: This analysis includes participants with high quality images that were able to be examined. Some participants moved during the MRI resulting in distorted images.

ArmMeasureGroupValue (MEAN)
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Insular Cortex0.3329 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Laterobasal Amygdala-0.203773 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Laterobasal Amygdala0.817701 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Frontal Orbital Cortex0.444076 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Frontal Orbital Cortex0.39487 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Amygdala0.13828 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Occipital Fusiform Gyrus0.336816 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Accumbens0.324295 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Insular Cortex0.347824 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Insular Cortex0.078993 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Amygdala0.221233 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Amygdala-0.192095 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Caudate0.086391 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Cingulate Gyrus, Anterior Division-0.13682 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Caudate0.241254 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Hippocampus0.86138 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Accumbens2.022323 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Accumbens-0.316604 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Cingulate Gyrus, Anterior Division-0.189082 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Cingulate Gyrus, Anterior Division0.313911 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Amygdala1.047957 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Caudate0.377711 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Laterobasal Amygdala-0.516251 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Frontal Orbital Cortex0.517829 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Amygdala0.147144 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Caudate-0.500704 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Accumbens0.893013 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Hippocampus-0.057242 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Laterobasal Amygdala-0.477913 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Accumbens0.821772 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Hippocampus-0.015598 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Occipital Fusiform Gyrus0.547858 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Amygdala0.505732 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Caudate0.050791 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Laterobasal Amygdala-0.50816 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Occipital Fusiform Gyrus3.427291 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Caudate-0.188575 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Amygdala-0.148364 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Accumbens1.430518 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Occipital Fusiform Gyrus0.684501 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Laterobasal Amygdala-0.003581 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Hippocampus0.699955 z-scores
Placebo in ASD ParticipantsBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Amygdala-0.119579 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Laterobasal Amygdala-0.247527 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Frontal Orbital Cortex0.084622 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Laterobasal Amygdala0.11396 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Accumbens-0.307024 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Occipital Fusiform Gyrus0.377043 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Laterobasal Amygdala-0.085989 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Cingulate Gyrus, Anterior Division-0.59443 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Amygdala0.567225 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Accumbens-1.05875 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Caudate0.916936 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Frontal Orbital Cortex-0.339727 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Hippocampus-0.093067 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Occipital Fusiform Gyrus3.556448 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Laterobasal Amygdala-0.46194 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Cingulate Gyrus, Anterior Division0.663003 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Occipital Fusiform Gyrus0.664895 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Laterobasal Amygdala-0.80763 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Amygdala0.735094 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Accumbens-0.358148 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Caudate-0.820473 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Hippocampus-0.391579 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Cingulate Gyrus, Anterior Division1.001123 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Amygdala-0.638315 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Accumbens-0.567634 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Caudate-0.698518 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Hippocampus-0.72534 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Amygdala0.512198 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Insular Cortex0.814225 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Amygdala-0.631298 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Frontal Orbital Cortex-0.195753 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Occipital Fusiform Gyrus-0.459616 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Amygdala0.328634 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Accumbens-1.177278 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Caudate0.132704 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Amygdala0.040877 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Hippocampus-0.154759 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Accumbens-0.129955 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Laterobasal Amygdala0.143468 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Caudate0.185452 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Amygdala-0.477983 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Insular Cortex-0.758427 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Caudate0.971035 z-scores
8IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Insular Cortex0.462527 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Laterobasal Amygdala0.347864 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Amygdala0.435674 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Occipital Fusiform Gyrus1.007465 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Occipital Fusiform Gyrus0.830858 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Occipital Fusiform Gyrus0.206772 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Laterobasal Amygdala0.276778 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Amygdala0.561367 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Amygdala0.175908 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Cingulate Gyrus, Anterior Division0.89113 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Accumbens0.984787 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Occipital Fusiform Gyrus3.403614 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Laterobasal Amygdala0.6247 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Frontal Orbital Cortex0.434074 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Caudate0.025731 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Hippocampus0.471703 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Frontal Orbital Cortex0.133334 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Amygdala1.009125 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Amygdala0.928212 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Accumbens1.396064 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Hippocampus0.716515 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Insular Cortex1.049595 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Accumbens0.565472 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Insular Cortex-0.602304 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Accumbens-0.418176 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Hippocampus0.194145 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Caudate1.197835 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Insular Cortex1.280621 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Caudate0.536007 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Accumbens1.752678 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Caudate-0.041339 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Cingulate Gyrus, Anterior Division1.064596 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Laterobasal Amygdala0.31737 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Hippocampus-0.033878 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Caudate0.58712 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Cingulate Gyrus, Anterior Division-0.922999 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Amygdala1.018509 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Caudate1.498338 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Amygdala0.078968 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Amygdala0.368682 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Accumbens-0.76235 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Laterobasal Amygdala0.57701 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Laterobasal Amygdala0.482033 z-scores
24IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Frontal Orbital Cortex0.243287 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Hippocampus-0.011004 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Caudate-0.602492 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Accumbens-0.556553 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Accumbens-0.777588 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Amygdala-0.922439 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Amygdala0.554755 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Amygdala1.091867 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Caudate-0.292749 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Insular Cortex0.33747 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Frontal Orbital Cortex0.51544 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Occipital Fusiform Gyrus3.39230 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Laterobasal Amygdala1.06647 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Laterobasal Amygdala0.989042 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Accumbens-0.364131 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Hippocampus0.485382 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Amygdala1.302074 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Caudate-0.280602 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Hippocampus0.295781 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Amygdala1.120718 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Frontal Orbital Cortex-0.625216 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Occipital Fusiform Gyrus0.32432 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Accumbens-0.776844 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Caudate0.00862 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Amygdala-0.62126 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Insular Cortex0.145474 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Cingulate Gyrus, Anterior Division0.239665 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Frontal Orbital Cortex-0.042926 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Occipital Fusiform Gyrus0.981023 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Laterobasal Amygdala-0.039061 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Laterobasal Amygdala-0.291652 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Accumbens-0.373102 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Caudate0.246921 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Cingulate Gyrus, Anterior Division0.03105 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Amygdala0.031841 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Accumbens-0.421539 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Caudate0.470775 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Hippocampus0.150852 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Amygdala0.659752 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Insular Cortex0.791272 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Cingulate Gyrus, Anterior Division0.906276 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Occipital Fusiform Gyrus1.263083 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Laterobasal Amygdala0.561114 z-scores
48IU of Oxytocin SprayBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Laterobasal Amygdala0.230971 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Amygdala2.214728 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Accumbens0.996732 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Insular Cortex0.779819 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Amygdala1.542177 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Caudate1.613145 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Laterobasal Amygdala1.905216 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Caudate1.577967 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Accumbens0.683166 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Amygdala1.078819 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Right Caudate1.470176 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Left Laterobasal Amygdala1.910744 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Hippocampus1.211722 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Left Accumbens1.059391 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Occipital Fusiform Gyrus0.795348 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesHappy versus Neutral, Frontal Orbital Cortex1.04841 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Right Amygdala1.683817 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Amygdala2.130943 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Amygdala1.65022 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Hippocampus0.632196 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Accumbens-1.532579 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Caudate0.017432 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Insular Cortex0.869933 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Amygdala1.701371 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Hippocampus0.613169 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Accumbens-0.859178 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Caudate0.232223 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Cingulate Gyrus, Anterior Division1.07742 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Right Laterobasal Amygdala1.03517 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Left Laterobasal Amygdala1.341538 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Occipital Fusiform Gyrus3.322934 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Cingulate Gyrus, Anterior Division-0.573381 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesNegative Emotions versus Neutral, Occipital Fusiform Gyrus0.926976 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Caudate1.354862 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Frontal Orbital Cortex0.504016 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Hippocampus1.203561 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Accumbens1.120372 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Laterobasal Amygdala1.808126 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Left Laterobasal Amygdala1.879398 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesFace versus Fixation, Insular Cortex-0.540874 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Right Amygdala1.60342 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Occipital Fusiform Gyrus0.967798 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Frontal Orbital Cortex1.116102 z-scores
Healthy Controls Receiving PlaceboBlood Oxygen Level Dependent (BOLD) Activity in Response to Social CuesEmotion versus Neutral, Cingulate Gyrus, Anterior Division1.267345 z-scores
Primary

Oxytocin Plasma Concentration

Plasma concentration of oxytocin prior to administration of study intervention and after administration of study intervention will be compared between the different dose levels and placebo. Plasma concentration of oxytocin is expected to increase following administration of intranasal oxytocin.

Time frame: Visits 1, 2, 3 and 4 (before spray and 5 minutes after spray)

Population: Only participants with ASD had blood drawn for plasma oxytocin concentrations. This analysis includes participants who provided a blood sample (one refused to give a sample).

ArmMeasureGroupValue (MEAN)Dispersion
Placebo in ASD ParticipantsOxytocin Plasma ConcentrationPrior to spray8.09 picogram/milliliterStandard Deviation 3.97
Placebo in ASD ParticipantsOxytocin Plasma ConcentrationAfter spray7.75 picogram/milliliterStandard Deviation 3.67
8IU of Oxytocin SprayOxytocin Plasma ConcentrationAfter spray14.36 picogram/milliliterStandard Deviation 9.28
8IU of Oxytocin SprayOxytocin Plasma ConcentrationPrior to spray11.17 picogram/milliliterStandard Deviation 6.99
24IU of Oxytocin SprayOxytocin Plasma ConcentrationPrior to spray9.06 picogram/milliliterStandard Deviation 3.45
24IU of Oxytocin SprayOxytocin Plasma ConcentrationAfter spray17.52 picogram/milliliterStandard Deviation 8.41
48IU of Oxytocin SprayOxytocin Plasma ConcentrationPrior to spray9.72 picogram/milliliterStandard Deviation 9.4
48IU of Oxytocin SprayOxytocin Plasma ConcentrationAfter spray20.86 picogram/milliliterStandard Deviation 12.66
Primary

Percent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game Task

BOLD activity in social-emotional brain regions during the perception of emotional facial videos were measured during the ball-game task. Mean percent change in contrast of parameter estimates in anatomical regions of interest are presented here. A positive value indicates increased BOLD activity while a negative value indicates decreased BOLD activity.

Time frame: Post Intervention (up to 70 minutes) at Study Visits 1, 2, 3, and 4

Population: This analysis includes participants with high quality images that were able to be examined. Some participants moved during the MRI resulting in distorted images.

ArmMeasureGroupValue (MEAN)Dispersion
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Anterior Cingulate (Sphere)0.2604 percent change in contrastStandard Error 0.1109
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Anterior Cingulate (Sphere)0.0175 percent change in contrastStandard Error 0.0501
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Frontal Orbital Cortex0.0142 percent change in contrastStandard Error 0.0428
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Nucleus Accumbens0.1139 percent change in contrastStandard Error 0.0675
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Laterobasal Amygdala0.1724 percent change in contrastStandard Error 0.0476
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Nucleus Accumbens-0.0277 percent change in contrastStandard Error 0.0354
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Laterobasal Amygdala0.1512 percent change in contrastStandard Error 0.0493
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Amygdala0.2568 percent change in contrastStandard Error 0.0563
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Ventral Anterior Insula (Sphere)0.1830 percent change in contrastStandard Error 0.0801
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Caudate0.0072 percent change in contrastStandard Error 0.0376
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Anterior Cingulate (Sphere)0.2774 percent change in contrastStandard Error 0.0854
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Frontal Orbital Cortex0.2263 percent change in contrastStandard Error 0.076
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Ventral Tegmental Area0.2412 percent change in contrastStandard Error 0.0738
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Amygdala0.3141 percent change in contrastStandard Error 0.0621
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Ventral Tegmental Area0.1417 percent change in contrastStandard Error 0.0448
Placebo in ASD ParticipantsPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Caudate0.2540 percent change in contrastStandard Error 0.0823
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Frontal Orbital Cortex0.1338 percent change in contrastStandard Error 0.036
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Laterobasal Amygdala0.0739 percent change in contrastStandard Error 0.0472
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Ventral Anterior Insula (Sphere)0.0311 percent change in contrastStandard Error 0.0574
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Amygdala0.1379 percent change in contrastStandard Error 0.0494
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Nucleus Accumbens0.1017 percent change in contrastStandard Error 0.0557
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Caudate0.0205 percent change in contrastStandard Error 0.0278
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Amygdala0.1118 percent change in contrastStandard Error 0.0452
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Frontal Orbital Cortex0.081 percent change in contrastStandard Error 0.0481
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Anterior Cingulate (Sphere)0.0996 percent change in contrastStandard Error 0.0564
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Anterior Cingulate (Sphere)0.0953 percent change in contrastStandard Error 0.063
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Anterior Cingulate (Sphere)0.0084 percent change in contrastStandard Error 0.0431
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Ventral Tegmental Area0.1010 percent change in contrastStandard Error 0.0528
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Caudate0.1114 percent change in contrastStandard Error 0.0512
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Nucleus Accumbens0.0528 percent change in contrastStandard Error 0.0354
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Ventral Tegmental Area-0.0175 percent change in contrastStandard Error 0.0391
8IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Laterobasal Amygdala0.0921 percent change in contrastStandard Error 0.0379
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Ventral Tegmental Area0.1889 percent change in contrastStandard Error 0.0769
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Laterobasal Amygdala0.1094 percent change in contrastStandard Error 0.0417
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Frontal Orbital Cortex0.1826 percent change in contrastStandard Error 0.0509
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Caudate0.1188 percent change in contrastStandard Error 0.044
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Nucleus Accumbens0.1174 percent change in contrastStandard Error 0.0352
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Anterior Cingulate (Sphere)0.0419 percent change in contrastStandard Error 0.0497
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Amygdala0.1631 percent change in contrastStandard Error 0.043
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Laterobasal Amygdala0.0984 percent change in contrastStandard Error 0.0362
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Caudate0.2605 percent change in contrastStandard Error 0.0753
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Ventral Anterior Insula (Sphere)-0.0575 percent change in contrastStandard Error 0.0661
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Frontal Orbital Cortex0.0826 percent change in contrastStandard Error 0.0412
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Nucleus Accumbens0.1779 percent change in contrastStandard Error 0.0575
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Anterior Cingulate (Sphere)0.1156 percent change in contrastStandard Error 0.0592
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Amygdala0.1979 percent change in contrastStandard Error 0.049
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Anterior Cingulate (Sphere)0.1526 percent change in contrastStandard Error 0.0711
24IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Ventral Tegmental Area0.0302 percent change in contrastStandard Error 0.0416
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Caudate0.2824 percent change in contrastStandard Error 0.0728
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Amygdala0.3304 percent change in contrastStandard Error 0.0658
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Amygdala0.3576 percent change in contrastStandard Error 0.0641
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Laterobasal Amygdala0.2569 percent change in contrastStandard Error 0.0666
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Laterobasal Amygdala0.2014 percent change in contrastStandard Error 0.0715
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Ventral Anterior Insula (Sphere)0.1866 percent change in contrastStandard Error 0.0872
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Anterior Cingulate (Sphere)0.3214 percent change in contrastStandard Error 0.078
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Anterior Cingulate (Sphere)0.2343 percent change in contrastStandard Error 0.0696
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Frontal Orbital Cortex0.1859 percent change in contrastStandard Error 0.0575
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Ventral Tegmental Area0.1770 percent change in contrastStandard Error 0.0879
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Nucleus Accumbens0.1341 percent change in contrastStandard Error 0.0642
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Anterior Cingulate (Sphere)-0.0996 percent change in contrastStandard Error 0.0443
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Frontal Orbital Cortex-0.0957 percent change in contrastStandard Error 0.0443
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Ventral Tegmental Area-0.0940 percent change in contrastStandard Error 0.081
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Caudate-0.0452 percent change in contrastStandard Error 0.0527
48IU of Oxytocin SprayPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Nucleus Accumbens-0.0615 percent change in contrastStandard Error 0.0417
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Frontal Orbital Cortex0.0286 percent change in contrastStandard Error 0.0359
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Ventral Tegmental Area0.0848 percent change in contrastStandard Error 0.0607
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Frontal Orbital Cortex0.2301 percent change in contrastStandard Error 0.0388
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Anterior Cingulate (Sphere)0.1218 percent change in contrastStandard Error 0.0594
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Amygdala0.3502 percent change in contrastStandard Error 0.0738
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Ventral Tegmental Area-0.0457 percent change in contrastStandard Error 0.0555
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Anterior Cingulate (Sphere)0.1406 percent change in contrastStandard Error 0.0525
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Ventral Anterior Insula (Sphere)0.0815 percent change in contrastStandard Error 0.0651
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Left Laterobasal Amygdala0.2717 percent change in contrastStandard Error 0.0555
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Nucleus Accumbens-0.0737 percent change in contrastStandard Error 0.0666
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Right Caudate-0.0057 percent change in contrastStandard Error 0.0576
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Laterobasal Amygdala0.2258 percent change in contrastStandard Error 0.0479
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive - Negative Feedback, Anterior Cingulate (Sphere)-0.0320 percent change in contrastStandard Error 0.0439
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Nucleus Accumbens0.2092 percent change in contrastStandard Error 0.0669
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Positive Feedback, Right Caudate0.3004 percent change in contrastStandard Error 0.0602
Healthy Controls Receiving PlaceboPercent Change in Blood Oxygen Level Dependent (BOLD) Activity During Ball-Game TaskHuman Minus Computer, Negative Feedback, Right Amygdala0.3823 percent change in contrastStandard Error 0.0796
Primary

Resting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)

Investigators will study the effects of intranasal oxytocin (IN-OT) on the resting state functional connectivity between key socio-emotional and social salience brain regions using functional magnetic resonance imaging (fMRI). Resting state functional connectivity is a task-independent metric of brain activity that is based on correlations between low-frequency fluctuations of the blood oxygen level-dependent signal between several brain regions. It reflects the strength of a functional connection that is in good agreement with the underlying neuroanatomy and provides a system-level understanding of brain function. Z-scores represent the number of standard deviations from the mean of 0 and range from -3 to +3, and z-scores greater than 0 indicate greater than average resting state functional connectivity.

Time frame: Post Intervention (Up to 40 minutes after receiving spray) at Study Visits 1, 2, 3 and 4

Population: This analysis includes participants with complete data for all visits. Two participants withdrew and data from another participant were not able to be analyzed due to technical problems during the MRI.

ArmMeasureValue (MEAN)Dispersion
Placebo in ASD ParticipantsResting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)0.338 z-scores rsFC salience-visualStandard Deviation 0.331
8IU of Oxytocin SprayResting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)0.400 z-scores rsFC salience-visualStandard Deviation 0.261
24IU of Oxytocin SprayResting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)0.428 z-scores rsFC salience-visualStandard Deviation 0.248
48IU of Oxytocin SprayResting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)0.522 z-scores rsFC salience-visualStandard Deviation 0.216
Healthy Controls Receiving PlaceboResting State Functional Connectivity (rsFC) Salience Network (Anterior Cingulate Cortex (ACC) and Insula Versus Visual Cortex)0.591 z-scores rsFC salience-visualStandard Deviation 0.214
Secondary

Milliseconds of Visual Fixation

Eye gaze will be recorded via an eye tracker inside the MRI scanner during the face perception task (FPT). Visual fixation between different treatment conditions will be assessed in ASD participants.

Time frame: Post Intervention (Up to 50 minutes) at Study Visits 1, 2, 3 and 4

Population: This analysis includes participants with ASD who had usable data for this outcome. There were difficulties with the eye tracking technology inside the MRI scanner and tracking of the pupil was not successful at all times. Healthy controls did not participate in the eye tracker portion of the study.

ArmMeasureValue (MEAN)Dispersion
Placebo in ASD ParticipantsMilliseconds of Visual Fixation91786.05 millisecondsStandard Deviation 65288.71
8IU of Oxytocin SprayMilliseconds of Visual Fixation82503.23 millisecondsStandard Deviation 48615.57
24IU of Oxytocin SprayMilliseconds of Visual Fixation134913.00 millisecondsStandard Deviation 55067.12
48IU of Oxytocin SprayMilliseconds of Visual Fixation130600.90 millisecondsStandard Deviation 66305.7
Secondary

Rate of Smiling During Global Clinical Interview

Clinical improvements will be rated by a clinician as based on a videotaped interview conducted after the MRI scanning session. Values between the different treatment conditions will be assessed to study the effect of intranasal oxytocin on ASD at the clinical level. The improvement will be assessed based on the quality of social interaction between the experimenter and the participant, specifically as the amount of smiling behavior displayed by participants. Larger values indicate that participants are smiling more frequently.

Time frame: Post Intervention (Up to 180 minutes after receiving spray) at Study Visits 1, 2, 3 and 4

Population: This analysis includes participants with ASD who completed the videotaped interview. One participant declined to be videotaped and is not included in this analysis.

ArmMeasureValue (MEAN)Dispersion
Placebo in ASD ParticipantsRate of Smiling During Global Clinical Interview0.954 Smiles per minuteStandard Deviation 0.724
8IU of Oxytocin SprayRate of Smiling During Global Clinical Interview0.954 Smiles per minuteStandard Deviation 0.801
24IU of Oxytocin SprayRate of Smiling During Global Clinical Interview1.013 Smiles per minuteStandard Deviation 0.81
48IU of Oxytocin SprayRate of Smiling During Global Clinical Interview1.015 Smiles per minuteStandard Deviation 0.744
Secondary

Social Learning Test (SLT) Reaction Time

During the SLT, participants complete an implicit association test using faces and words. The faces that are presented in this task are partners' faces with whom participants played during the ball-game inside the MRI scanner. In this task, there are congruent blocks where neutral faces of positive partners are presented with friendly words and neutral faces of negative partners are presented with unfriendly words. During incongruent blocks, neutral faces of positive partners are presented with unfriendly words and neutral faces of negative partners are presented with friendly words. Participants match the face or the word to one of two categories. Longer reaction time indicates difficulty with selecting a category. Longer reaction time in incongruent trials signifies implicit biases were formed for the positive and negative players such that positive partners from the ball-game are now perceived as friendly and negative partners are now perceived as unfriendly.

Time frame: Post Intervention (Up to 130 minutes) at Study Visits 1, 2, 3 and 4

Population: Among participants with autism who completed the study, two participants had outlying data and were removed from this analysis.Two healthy controls did not complete the SLT due to time constraints.

ArmMeasureGroupValue (MEAN)Dispersion
Placebo in ASD ParticipantsSocial Learning Test (SLT) Reaction TimeCongruent Blocks939.43 millisecondsStandard Deviation 605.79
Placebo in ASD ParticipantsSocial Learning Test (SLT) Reaction TimeIncongruent Blocks969.17 millisecondsStandard Deviation 730.3
Placebo in ASD ParticipantsSocial Learning Test (SLT) Reaction TimeTraining Blocks790.49 millisecondsStandard Deviation 757.66
8IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeIncongruent Blocks960.41 millisecondsStandard Deviation 745.84
8IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeTraining Blocks800.25 millisecondsStandard Deviation 922.21
8IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeCongruent Blocks972.08 millisecondsStandard Deviation 950.41
24IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeCongruent Blocks905.99 millisecondsStandard Deviation 741.22
24IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeTraining Blocks765.53 millisecondsStandard Deviation 754.48
24IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeIncongruent Blocks920.23 millisecondsStandard Deviation 622.83
48IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeTraining Blocks761.89 millisecondsStandard Deviation 782.89
48IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeCongruent Blocks896.63 millisecondsStandard Deviation 679.5
48IU of Oxytocin SpraySocial Learning Test (SLT) Reaction TimeIncongruent Blocks921.90 millisecondsStandard Deviation 650.23
Healthy Controls Receiving PlaceboSocial Learning Test (SLT) Reaction TimeIncongruent Blocks791.65 millisecondsStandard Deviation 410.01
Healthy Controls Receiving PlaceboSocial Learning Test (SLT) Reaction TimeCongruent Blocks762.72 millisecondsStandard Deviation 335.81
Healthy Controls Receiving PlaceboSocial Learning Test (SLT) Reaction TimeTraining Blocks655.27 millisecondsStandard Deviation 499.78

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026